Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in April/May 2020 and August 2019
General Info
Coverage type
Country
Time period covered
August, 2019 - May, 2020
Data type
Survey
Summary
A total of 900 residual sera from nine laboratories were sampled in week numbers 17-20, 2020, and tested for antibodies against SARS-CoV-2 using a novel in-house assay established at the Department of Immunology, Oslo University Hospital. Based on these measurements, the estimated seroprevalence in the Norwegian population is probably close to 1% (1.0% (95% credible interval 0.1% -2.4%)).
Keywords
Citation
Publisher
Publication year
2020
Suggested citation
Norwegian Institute of Public Health, Oslo University Hospital. Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in April/May 2020 and August 2019. Oslo, Norway: Norwegian Institute of Public Health, 2020.